Serial #79278928
LIVE

Serial Number

79278928

Owner

NOVARTIS AG

Attorney

Maury M. Tepper, III

Filing Date

Dec 5, 2019

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79278928 Trademark

Serial Number: 79278928 • Registration: 6110298

Serial #79278928 is a trademark filed by NOVARTIS AG on December 5, 2019. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,165 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

December 5, 2019

Registration Date

July 28, 2020

Published for Opposition

May 12, 2020

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Jul 28, 2025 REM3
FINAL DECISION TRANSACTION PROCESSED BY IB
Dec 6, 2020 FINV
FINAL DISPOSITION NOTICE SENT TO IB
Nov 17, 2020 FICS
FINAL DISPOSITION PROCESSED
Nov 17, 2020 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Oct 28, 2020 FICR
REGISTERED-PRINCIPAL REGISTER
Jul 28, 2020 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 12, 2020 NPUB
PUBLISHED FOR OPPOSITION
May 12, 2020 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 22, 2020 NONP
REFUSAL PROCESSED BY IB
Apr 10, 2020 RFNT
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 1, 2020 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 27, 2020 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 26, 2020 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 26, 2020 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 24, 2020 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 24, 2020 TCCA
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Mar 24, 2020 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 24, 2020 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 24, 2020 REAP
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 24, 2020 COAR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2020 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2020 RFRR
APPLICATION FILING RECEIPT MAILED
Mar 3, 2020 MAFR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 29, 2020 RFCR
NON-FINAL ACTION WRITTEN
Feb 28, 2020 CNRT
ASSIGNED TO EXAMINER
Feb 27, 2020 DOCK
ASSIGNED TO EXAMINER
Feb 27, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 26, 2020 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Feb 24, 2020 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Feb 20, 2020 REPR